This review reports the results of application of short peptides in glioma therapy clinical trials, their rises and falls.
Browsing: Taxonomy > Clinical trials
In this interview with Francesco Lo-coco we discussed a randomized clinical trial conducted with the drug Trisenox as well as, the genetic characterization, monitoring and treatment of hematologic tumors, particularly acute promyelocytic leukemia.
This article summarizes the outcome of a randomized phase III clinical trial investigating the effect of FLT3 inhibitors to improve FTL3-mutated acute myeloid leukemia
What are the current limitation with clinical trials for AML? This review discusses trial end points, patient enrollment, cost of drug discovery and patient heterogeneity and future treatment of AML.
A team of investigators on the Head Start III trial have highlighted that patients with reduced radiotherapy experience a worse prognosis following deviations from the treatment protocol.
In this editorial from Melanoma Management the authors examine melanoma clinical trials with a focus upon targeted therapies and melanoma vaccines.
Phase I data indicate that nivolumab significantly increases long-term survival in previously treated, advanced non-small-cell lung cancer.
In this special report from Future Oncology the authors review the current literature on early salvage radiotherapy post-prostatectomy and provide key insights on the future of this therapy.
To mark Triple-Negative Breast Cancer Day, take a look at our new and exclusive summary infographic presenting some of the key facts about triple-negative breast cancer.